Fresenius Medical Care

How do we move beyond diffusion alone to improve the outcomes for patients on dialysis?     In our latest Research in Brief, Karin Bergling, MD, PhD, from the Renal Research Institute (RRI), and Peter Blankestijn, MD, PhD, from the University Medical Center Utrecht, discuss clinical perspectives on two convection-enhancing therapies: online hemodiafiltration (HDF) and medium cut-off (MCO) dialyzers.     The clinical and patient-reported outcome evidence for online HDF is strong – especially at convection volumes exceeding 23 liters – while data on MCO dialyzers is scarce. The takeaway: These findings support a shift toward more personalized dialysis prescriptions.     Watch the full interview now and read the article to learn more: https://lnkd.in/d2wXGAgM #ResearchInBrief #KidneyCare #Innovation #ForOurPatients #ProudToBeFME

Yesterday, we concluded Fresenius Medical Care’s Annual General Meeting 2026. Thank you to our shareholders and to everyone who joined us – either live from the Congress Center in Frankfurt or virtually. The meeting included updates on our performance, strategic priorities, and the road ahead, along with speeches from the Chair of our Supervisory Board, Michael Sen, and our CEO, Helen Giza. If you missed the AGM, you can watch the webcast here: https://lnkd.in/eTvm92-G #AnnualGeneralMeeting #AGM2026 #InvestorRelations #ProudToBeFME

¿Qué ocurre cuando la vida cambia por completo… pero decides seguir escribiendo tu propia historia? ✍️ La experiencia de Esther nos recuerda que la enfermedad renal no tiene por qué poner fin a los sueños, sino transformarlos. Desde muy joven, ha convivido con la enfermedad renal, enfrentándose a múltiples tratamientos, trasplantes y largas etapas de hospitalización. Una realidad compleja y, muchas veces, invisible para quienes no la viven de cerca. Y, sin embargo, su historia no se detiene ahí. A pesar de las dificultades, Esther ha seguido formándose, trabajando y desarrollando su vocación. Porque cuando existe determinación, incluso en los momentos más difíciles, es posible construir un camino propio. Su historia es también una llamada a visibilizar una realidad que muchas veces pasa desapercibida: el esfuerzo diario que implica vivir en diálisis, las limitaciones, los retos… pero también la capacidad de adaptación, resiliencia y superación. 🌍 En FME trabajamos cada día para que las personas con enfermedad renal puedan seguir desarrollando su vida personal y profesional, acompañándolas en cada etapa y facilitando que continúen cumpliendo sus objetivos. Porque la enfermedad forma parte de la vida, pero no define quién eres ni hasta dónde puedes llegar. Descubre su historia completa 👇 🔗 https://lnkd.in/eNyZZRVf #NephroCare #HistoriasQueInspiran #SaludRenal #VidaLaboral #Pacientes #Humanización #Healthcare #Superación

Today, we held our 2026 Annual General Meeting at the Congress Center Messe in Frankfurt, Germany. It was an important moment to look back on a strong year – shaped by the launch of our FME Reignite in June 2025 and by the culmination of our multi-year effort to fundamentally strengthen our Company as part of our FME25 turnaround and transformation. In their speeches, Michael Sen, Chair of the Supervisory Board, and Helen Giza, CEO and Chair of the Management Board of Fresenius Medical Care, emphasized a clear message: by delivering on our key commitments, Fresenius Medical Care strengthened its competitiveness and resilience. Our shareholders expressed strong support. With 78.71% of share capital represented, a dividend of €1.49 per share was approved, representing a 3% year‑over‑year increase. They also acknowledged the successful completion of our share buyback program and approved a new authorization, reflecting continued confidence in our financial strength and supporting our capital allocation framework, which includes further share buyback programs. With these outcomes, Fresenius Medical Care is well positioned for continued earnings growth in 2026 and beyond. All agenda items were approved. Thank you to our colleagues around the world – your dedication made another successful year possible. 👉 Read the full AGM 2026 voting results and press release: https://lnkd.in/ewk38gpj #AnnualGeneralMeeting #AGM2026 #InvestorRelations #ProudToBeFME

The Supervisory Board of Fresenius Medical Care today has reappointed Martin Fischer, Chief Financial Officer and Member of the Management Board, for a period of five years until 2031.   Michael Sen, Chairman of the Supervisory Board, said, “Over the past few years, Martin Fischer has made a significant contribution to driving forward the transformation of Fresenius Medical Care. We are therefore very pleased that he will continue to serve the company.” Read the press release: https://lnkd.in/ezdqJyBk #News #PressRelease #Announcement #ManagementBoard #Leadership #ProudToBeFME

Preparations are in full swing for Fresenius Medical Care’s Annual General Meeting 2026. We look forward to welcoming our shareholders for tomorrow’s event. Join us live at 10:00 CET from the Congress Center Messe in Frankfurt, Germany, to hear from Michael Sen, Chair of the Supervisory Board, and Helen Giza, CEO and Chair of the Management Board of Fresenius Medical Care. Those attending virtually can tune in via our website to follow the speeches live: https://lnkd.in/ehJpT29g #AnnualGeneralMeeting #AGM2026 #InvestorRelations #ProudToBeFME

The Power of Care lives in the moments that matter most. It is found in the trust our nurses and care teams build, the reassurance they provide when it’s needed most, and the expertise they bring to every patient, every moment, and every day. Following on U.S National Nurses Week and #InternationalNursesDay, we continue to celebrate how these individual "moments of care" collectively bring our mission to life. Whether supporting patients in-center or through home therapies, our teams don’t just deliver care, they provide comfort and safety. 💙 We take great pride in the nurses and care teams whose expertise and dedication make this impact possible, every single day. Watch how these moments of care transcend borders, from Ireland to the U.S. 👉 Discover the full story here: https://lnkd.in/eTFej9uN #IND2026 #NationalNursesWeek #INDatFME #ProudToBeFME

📢 We’re excited to be part of the 63rd ERA Congress in Glasgow, June 3-6, 2026. At this year’s congress, we look forward to engaging with healthcare professionals, partners, and experts from around the world, as meaningful exchange and collaboration are essential to shaping the future of kidney care and advancing our shared impact. As a committed partner, we support our customers to achieve their goals through continuous innovation, measurable impact, and strong partnerships, delivering progress that truly matters for every life. Visit us at Booth C.210 and see how we provide a complete and integrated system of products and services across the entire patient on dialysis pathway, addressing diverse clinical needs. We look forward to participating in this important congress, exchanging ideas, and connecting with participants from around the globe. See you in Glasgow! 👉 Register now: https://lnkd.in/e2kqcKNQ Please note: This post is intended for healthcare professionals. #ERA26 #FreseniusMedicalCare #ForEveryLife #ProudToBeFME

Did you know that high blood pressure can damage the kidneys, while kidney disease itself can also make hypertension worse? Because both conditions often develop silently with no obvious symptoms, many people may not realize there’s an issue until significant damage has already occurred. Ahead of World Hypertension Day this Sunday, May 17, we’re raising awareness about the important connection between blood pressure and kidney health, why early monitoring matters, and how lifestyle choices and treatment options may help support long-term well-being. From prevention strategies to advances in chronic kidney disease care, discover why protecting one may help protect the other in our latest article: https://lnkd.in/d9UDtaUS #WorldHypertensionDay #HypertensionAwareness #BloodPressureAwareness #KidneyHealth #ProudToBeFME

We are proud to be recognized for our sustainability performance with the inclusion in the Dow Jones Best-in-Class World and Europe Indices. The reflects our continued commitment to sustainable development across our global operations – keeping patients at the center of everything we do. Learn more in our 2025 Sustainability Statement: https://lnkd.in/dHH_ZeNr #Sustainability #DJBIC #ProudToBeFME